Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.

Handrup MM, Fuursted K, Funch P, Møller JK, Schrøder H.

APMIS. 2012 Oct;120(10):794-801. doi: 10.1111/j.1600-0463.2012.02910.x.

PMID:
22958287
2.

Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.

Dümichen MJ, Seeger K, Lode HN, Kühl JS, Ebell W, Degenhardt P, Singer M, Geffers C, Querfeld U.

J Hosp Infect. 2012 Apr;80(4):304-9. doi: 10.1016/j.jhin.2012.01.003.

PMID:
22342714
3.

Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.

Handrup MM, Møller JK, Schrøder H.

Pediatr Blood Cancer. 2013 Aug;60(8):1292-8. doi: 10.1002/pbc.24482.

PMID:
23417891
4.

Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.

Betjes MG, van Agteren M.

Nephrol Dial Transplant. 2004 Jun;19(6):1546-51.

PMID:
14993498
5.
6.

A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.

Zwiech R, Adelt M, Chrul S.

Am J Ther. 2016 Mar-Apr;23(2):e363-8. doi: 10.1097/MJT.0b013e31828d4610.

PMID:
23665885
8.

Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.

Bosma JW, Siegert CE, Peerbooms PG, Weijmer MC.

Nephrol Dial Transplant. 2010 Apr;25(4):1213-7. doi: 10.1093/ndt/gfp651.

PMID:
19948873
9.

Treatment of long-term catheter-related bloodstream infections with a taurolidine block: a single cancer center experience.

Haag GM, Berger AK, Jäger D.

J Vasc Access. 2011 Jul-Sep;12(3):244-7. doi: 10.5301/JVA.2011.6265.

PMID:
21279949
10.

Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.

Aybar Y, Ozaras R, Besirli K, Engin E, Karabulut E, Salihoglu T, Mete B, Tabak F, Mert A, Tahan G, Yilmaz MH, Ozturk R.

Int J Antimicrob Agents. 2012 Apr;39(4):338-42. doi: 10.1016/j.ijantimicag.2012.01.001.

PMID:
22364717
11.

Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.

Murray EC, Deighan C, Geddes C, Thomson PC.

QJM. 2014 Dec;107(12):995-1000. doi: 10.1093/qjmed/hcu128.

PMID:
24939191
12.

A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.

Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schulz M, Diggle P.

Am J Kidney Dis. 2010 Jun;55(6):1060-8. doi: 10.1053/j.ajkd.2009.11.025.

PMID:
20207458
13.

Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.

Solomon LR, Cheesbrough JS, Bhargava R, Mitsides N, Heap M, Green G, Diggle P.

Semin Dial. 2012 Mar-Apr;25(2):233-8. doi: 10.1111/j.1525-139X.2011.00951.x.

PMID:
21916999
14.
15.

Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.

Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G.

Nephrol Dial Transplant. 2008 Aug;23(8):2604-10. doi: 10.1093/ndt/gfn023.

PMID:
18332071
16.

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.

Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ.

Clin Nutr. 2010 Aug;29(4):464-8. doi: 10.1016/j.clnu.2009.12.005.

PMID:
20061070
17.

Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.

Al-Amin AH, Sarveswaran J, Wood JM, Burke DA, Donnellan CF.

J Vasc Access. 2013 Oct-Dec;14(4):379-82. doi: 10.5301/jva.5000168.

PMID:
23817948
19.

Antimicrobial activity of a novel catheter lock solution.

Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R, Mermel LA.

Antimicrob Agents Chemother. 2002 Jun;46(6):1674-9.

20.

Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.

Klek S, Szczepanek K, Hermanowicz A, Galas A.

JPEN J Parenter Enteral Nutr. 2015 Mar;39(3):331-5. doi: 10.1177/0148607114525804.

PMID:
24604029

Supplemental Content

Support Center